Intraductal Carcinoma Of The Prostate: Indicator Of Aggressive Disease

Grant number: 1077799 | Funding period: 2015 - 2018



This proposal addresses the need to improve personalised treatment decisions for men with high risk familial prostate cancer as they have a very aggressive disease progression with a very poor clinical outcome. We will perform biological and pre-clinical studies to improve the clinical diagnosis, prognosis and treatment options for men with germline mutations in BRCA2 or BRCA1 genes who develop prostate cancer.